Gts Securities LLC Lantheus Holdings, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$77.7 - $123.62 $473,970 - $754,082	6,100 Added 24.5%	31,000 $3.4 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $423,864 - $597,960	-7,200 Reduced 22.43%	24,900 $2 Million
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $3.83 Million - $5.11 Million	-74,900 Reduced 70.0%	32,100 $2 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $5.58 Million - $7.81 Million	100,300 Added 1497.01%	107,000 $6.63 Million
Q3 2023 Nov 15, 2023	BUY	$60.27 - $90.75 $403,809 - $608,025	6,700 New	6,700 $465,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.